Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2026-02-24 00:00:00 ET · period of report 2026-02-20 · accession 0001159036-26-000031 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-24 | 2026-02-20 | HALO | Caudill Cortney | SVP, COO | M - OptEx | $0.00 | +2,666 | 15.4K | +21% | $0 |
| D | 2026-02-24 | 2026-02-20 | HALO | Caudill Cortney | SVP, COO | F - Tax | $70.98 | -1,037 | 14.4K | -7% | -$73.6K |
| D | 2026-02-24 | 2026-02-20 | HALO | Caudill Cortney | SVP, COO | M - OptEx | $0.00 | -2,666 | 7,998 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-20 | M | A | 2,666 | $0.00 | 15,403 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-20 | F | D | 1,037 | $70.98 | 14,366 | D | — | — | (F1) The reported disposition of 1,037 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 3 | Derivative | Restricted Stock Units | 2026-02-20 | M | D | 2,666 | $0.00 | 7,998 | D | $0.00 · 2026-02-20 to — | 2,666 Common Stock | (F2) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |